ATE221537T1 - Neue (alpha-aminophosphino) peptide, verfahren zu ihrer herstellung und ihre therapeutische verwendung - Google Patents

Neue (alpha-aminophosphino) peptide, verfahren zu ihrer herstellung und ihre therapeutische verwendung

Info

Publication number
ATE221537T1
ATE221537T1 AT97911309T AT97911309T ATE221537T1 AT E221537 T1 ATE221537 T1 AT E221537T1 AT 97911309 T AT97911309 T AT 97911309T AT 97911309 T AT97911309 T AT 97911309T AT E221537 T1 ATE221537 T1 AT E221537T1
Authority
AT
Austria
Prior art keywords
aminophosphino
peptides
alpha
new
production
Prior art date
Application number
AT97911309T
Other languages
English (en)
Inventor
Marie-Claude Fournie-Zaluski
Huixiong Chen
Bernard Pierre Roques
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE221537T1 publication Critical patent/ATE221537T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211—Esters of acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97911309T 1996-10-25 1997-10-21 Neue (alpha-aminophosphino) peptide, verfahren zu ihrer herstellung und ihre therapeutische verwendung ATE221537T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9613082A FR2755135B1 (fr) 1996-10-25 1996-10-25 Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent
PCT/FR1997/001884 WO1998018803A1 (fr) 1996-10-25 1997-10-21 NOUVEAUX DERIVES D'(α-AMINOPHOSPHINO)PEPTIDES, LEUR PROCEDE DE PREPARATION ET LEURS APPLICATIONS THERAPEUTIQUES

Publications (1)

Publication Number Publication Date
ATE221537T1 true ATE221537T1 (de) 2002-08-15

Family

ID=9497061

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97911309T ATE221537T1 (de) 1996-10-25 1997-10-21 Neue (alpha-aminophosphino) peptide, verfahren zu ihrer herstellung und ihre therapeutische verwendung

Country Status (13)

Country Link
US (1) US6518260B1 (de)
EP (1) EP1009750B1 (de)
JP (1) JP2001504815A (de)
AR (1) AR009129A1 (de)
AT (1) ATE221537T1 (de)
AU (1) AU4873197A (de)
CA (1) CA2266514A1 (de)
DE (1) DE69714475T2 (de)
DK (1) DK1009750T3 (de)
ES (1) ES2180950T3 (de)
FR (1) FR2755135B1 (de)
WO (1) WO1998018803A1 (de)
ZA (1) ZA979573B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777780B1 (fr) * 1998-04-22 2001-05-04 Inst Nat Sante Rech Med Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent
FR2781230B1 (fr) * 1998-07-02 2000-09-01 Commissariat Energie Atomique Derives de peptides utilisables comme inhibiteur selectif du site n-terminal de l'enzyme de conversion de l'angiotensine humaine
FR2823212B1 (fr) * 2001-04-10 2005-12-02 Inst Nat Sante Rech Med Inhibiteurs de la toxine botulique de type b
FR2882752B1 (fr) * 2005-03-01 2007-05-04 Servier Lab Nouveaux derives d'aminoacides phosphiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2931151A1 (fr) 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
FR2934267B1 (fr) 2008-07-23 2010-08-13 Pharmaleads Derives aminophosphiniques utiles dans le traitement de la douleur
SG176010A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminobutyric derivatives as neprilysin inhibitors
JP5420761B2 (ja) 2009-05-28 2014-02-19 ノバルティス アーゲー ネプリリシン阻害剤としての置換アミノプロピオン酸誘導体
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
FR2997081B1 (fr) 2012-10-23 2015-11-27 Pharmaleads Inhibiteurs mixtes de l'aminopeptidase n et de la neprilysine
NZ710574A (en) 2013-02-14 2017-11-24 Novartis Ag Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
WO2014126972A1 (en) 2013-02-14 2014-08-21 Novartis Ag Substituted bisphenyl butanoic acid derivatives as nep inhibitors with improved in vivo efficacy
GR1008310B (el) * 2013-10-03 2014-10-02 Εκεφε Δημοκριτος, Φωσφινικα ψευδοπεπτιδικα παραγωγα για την αποτελεσματικη αναστολη αμινοπεπτιδασων της υπο-οικογενειας οκυτοκινασων της οικογενειας μ1 αμινοπεπτιδασων
FR3044227B1 (fr) 2015-11-30 2017-11-24 Pharmaleads Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires
WO2017093093A1 (en) * 2015-11-30 2017-06-08 Dsm Ip Assets B.V. Phosphinic peptide derivatives for use as mmp-12 inhibitors
CN110352060A (zh) 2017-03-09 2019-10-18 领先药物公司 用于预防和治疗眼部炎症的氨基次膦酸衍生物
FR3063635B1 (fr) * 2017-03-09 2019-06-07 Pharmaleads Derives aminophosphiniques pour la prevention et le traitement de l'inflammation oculaire
FR3077201B1 (fr) 2018-01-26 2020-01-17 Pharmaleads Derives aminoacides contenant un groupement disulfanyle sous forme d'un inhibiteur de nep et d'apn pour la prevention et le traitement des douleurs relatives au nerf trijumeau
FR3098217B1 (fr) 2019-07-05 2023-04-21 Pharmaleads N-Formylhydroxylamines en tant qu’inhibiteurs mixtes de l’aminopeptidase N (APN) et de la néprilysine (NEP)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651229B1 (fr) * 1989-08-24 1991-12-13 Inst Nat Sante Rech Med Nouveaux derives d'amino-acides, leur procede de preparation et leur application therapeutique.
IT1270260B (it) * 1994-06-21 1997-04-29 Zambon Spa Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
FR2730235A1 (fr) * 1995-02-06 1996-08-09 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteur de l'endopeptidase a zinc 24-15

Also Published As

Publication number Publication date
EP1009750A1 (de) 2000-06-21
DE69714475T2 (de) 2003-04-10
WO1998018803A1 (fr) 1998-05-07
JP2001504815A (ja) 2001-04-10
ZA979573B (en) 1998-05-21
DK1009750T3 (da) 2002-12-16
EP1009750B1 (de) 2002-07-31
FR2755135B1 (fr) 2002-12-27
DE69714475D1 (de) 2002-09-05
ES2180950T3 (es) 2003-02-16
FR2755135A1 (fr) 1998-04-30
AR009129A1 (es) 2000-03-08
AU4873197A (en) 1998-05-22
CA2266514A1 (en) 1998-05-07
US6518260B1 (en) 2003-02-11

Similar Documents

Publication Publication Date Title
DE69714475D1 (de) Neue (alpha-aminophosphino) peptide, verfahren zu ihrer herstellung und ihre therapeutische verwendung
ATE206131T1 (de) Phosphonomonoesternnukleinsäuren, verfahren zu ihrer herstellung und ihre verwendung
FI973543A0 (fi) Menetelmä heteromultimeeristen polypeptidien valmistamiseksi
EP1107976A4 (de) Anti-endotoxische, antimikrobielle kationische peptide und verfahren zu ihrer verwendung
DE69707849D1 (de) Verfahren zur reinigung von 1,4-butandiol
DE69530989D1 (de) Neue pyrimidinderivate und verfahren zu ihrer herstellung
DE69730259D1 (de) Schichtstoff und Verfahren zu dessen Herstellung
DE69814891D1 (de) Zusammengesetzte umkehrosmosemembran und verfahren zu ihrer herstellung
DE59707078D1 (de) Monoolefinische c 5-mononitrile, verfahren zu ihrer herstellung und ihrer verwendung
DE69432231D1 (de) Peptide mit antithrombotischer aktivität und verfahren zu ihrer herstellung
DE59707976D1 (de) Neue guanidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE250686T1 (de) Vliesverbund, verfahren zu dessen herstellung und dessen verwendung
DE59706810D1 (de) Von cyclopenten abgeleitete oligomerengemische, verfahren zu ihrer herstellung und ihre verwendung
DE59802412D1 (de) Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
DE69710078D1 (de) Verfahren zur reinigung von 1,1,1,3,3-pentafluorpropan
DE59809728D1 (de) Verfahren zur herstellung von reinem flupirtin-maleat und dessen modifikation a
FI980853A0 (fi) Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta
DE69709655D1 (de) Verfahren zur herstellung von 17-estern von 9alpha,21-dihalopregan-11beta,17alpha-diol-20-onen
DE59810658D1 (de) Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung desselben
DE19681160D2 (de) Polypeptide mit IL-16-Aktivität, Verfahren zu ihrer Herstellung und Verwendung
EP0622369A3 (de) 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE59609207D1 (de) Farbstoffmischungen, Verfahren zu ihrer Herstellung und ihre Verwendung
AT399880B (de) Neue thienothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE69734761D1 (de) Aus hemophilus paragallinarum abstammendes polypeptid und verfahren zu dessen herstellung
ATE263755T1 (de) Neue antiestrogene, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties